MA53294A - Préparation de bactériophages - Google Patents

Préparation de bactériophages

Info

Publication number: MA53294A
Authority: MA; Morocco
Prior art keywords: bacteriophage preparation; bacteriophage; preparation
Prior art date: 2018-08-10

Application number

MA053294A

Other languages

English (en)

Inventor

Jumpei Fujiki

Hidetoshi Higuchi

Hidetomo Iwano

Yutaka Tamura

Masaru Usui

Original Assignee

Incorporated Educational Inst Rakuno Gakuen

Meiji Seika Pharma Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2018-08-10

Filing date

2019-08-09

Publication date

2022-05-04

2019-08-09 Application filed by Incorporated Educational Inst Rakuno Gakuen, Meiji Seika Pharma Co Ltd filed Critical Incorporated Educational Inst Rakuno Gakuen

2022-05-04 Publication of MA53294A publication Critical patent/MA53294A/fr

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10111—Myoviridae
- C12N2795/10121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10111—Myoviridae
- C12N2795/10131—Uses of virus other than therapeutic or vaccine, e.g. disinfectant
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10111—Myoviridae
- C12N2795/10132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Virology (AREA)
Microbiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Mycology (AREA)
Biomedical Technology (AREA)
General Engineering & Computer Science (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Immunology (AREA)
Dermatology (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

MA053294A 2018-08-10 2019-08-09 Préparation de bactériophages MA53294A (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP2018151950		2018-08-10

Publications (1)

Publication Number	Publication Date
MA53294A true MA53294A (fr)	2022-05-04

Family

ID=69414263

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA053294A MA53294A (fr)	2018-08-10	2019-08-09	Préparation de bactériophages

Country Status (8)

Country	Link
US (1)	US20210290702A1 (fr)
EP (1)	EP3834835A4 (fr)
JP (1)	JPWO2020032232A1 (fr)
CN (1)	CN113038960A (fr)
BR (1)	BR112021002417A2 (fr)
CA (1)	CA3108051A1 (fr)
MA (1)	MA53294A (fr)
WO (1)	WO2020032232A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2021079435A1 (fr) *	2019-10-23	2021-04-29	ＭｅｉｊｉＳｅｉｋａファルマ株式会社	Composition bactériophage
WO2021079986A1 (fr) *	2019-10-23	2021-04-29	ＭｅｉｊｉＳｅｉｋａファルマ株式会社	Composition bactériophage
WO2021157732A1 (fr) *	2020-02-07	2021-08-12	ＭｅｉｊｉＳｅｉｋａファルマ株式会社	Agent destiné à être utilisé comme bactériophage
CN111893198B (zh) *	2020-07-16	2021-04-20	广东省微生物研究所（广东省微生物分析检测中心）	用于银白色葡萄球菌鉴定的特异性分子靶标、检测引物组及其快速检测方法
CN115261334B (zh) *	2021-07-02	2023-06-27	青岛诺安百特生物技术有限公司	一株葡萄球菌噬菌体、噬菌体制剂及其在防治葡萄球菌感染的疾病中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5647232A (en)	1979-09-25	1981-04-28	Honda Motor Co Ltd	Ring rolling apparatus
DE60007668T2 (de)	1999-01-26	2004-12-02	Akzo Nobel N.V.	Verwendung lebender abgeschwächter Bakterien zur Herstellung eines submukosalen Impstoffes
JP2004283003A (ja)	2003-01-31	2004-10-14	Rikogaku Shinkokai	バクテリオファージによる大腸菌の検出
KR101021041B1 (ko) *	2008-06-09	2011-03-15	주식회사 인트론바이오테크놀로지	유효성분으로 박테리오파지를 포함하는 선박 평형수 처리용조성물 및 이를 이용한 선박 평형수에 존재하는박테리아의 생물학적 제거 방법
CA2729160C (fr) *	2008-07-03	2017-11-14	The Rockefeller University	Lysine chimerique de bacteriophage presentant une activite contre les bacteries staphylocoques
JP5720045B2 (ja) *	2008-12-26	2015-05-20	国立大学法人東京工業大学	スタフィロコッカス・アウレウス溶菌性バクテリオファージ
US20170157186A1 (en) *	2015-12-02	2017-06-08	Smart Phage, Inc.	Phage to treat bacteria on skin
CN107779439B (zh) *	2016-08-24	2021-02-02	菲吉乐科(南京)生物科技有限公司	新的葡萄球菌噬菌体及其组合物、制备方法和应用
US10695386B2 (en) *	2017-05-11	2020-06-30	Shayne K. Morris	Skin microbiome colonizer formulations and methods for use
CN107779440B (zh) *	2017-11-02	2019-10-18	青岛诺安百特生物技术有限公司	一种葡萄球菌噬菌体及其在葡萄球菌感染中的应用
WO2021079435A1 (fr) *	2019-10-23	2021-04-29	ＭｅｉｊｉＳｅｉｋａファルマ株式会社	Composition bactériophage
JP7514493B2 (ja) *	2021-08-25	2024-07-11	学校法人酪農学園	メチシリン耐性黄色ブドウ球菌（ｍｒｓａ）に対する抗菌薬の薬剤感受性を向上させるための組成物、ｍｒｓａ感染症を治療又は予防するための組成物及びｍｒｓａの病原性を低下させるための組成物

2019
- 2019-08-09 JP JP2020535902A patent/JPWO2020032232A1/ja active Pending
- 2019-08-09 WO PCT/JP2019/031559 patent/WO2020032232A1/fr not_active Ceased
- 2019-08-09 US US17/266,232 patent/US20210290702A1/en not_active Abandoned
- 2019-08-09 CN CN201980053337.XA patent/CN113038960A/zh active Pending
- 2019-08-09 MA MA053294A patent/MA53294A/fr unknown
- 2019-08-09 EP EP19848283.8A patent/EP3834835A4/fr not_active Withdrawn
- 2019-08-09 CA CA3108051A patent/CA3108051A1/fr not_active Abandoned
- 2019-08-09 BR BR112021002417-4A patent/BR112021002417A2/pt not_active Application Discontinuation

Also Published As

Publication number	Publication date
US20210290702A1 (en)	2021-09-23
EP3834835A4 (fr)	2022-05-04
EP3834835A1 (fr)	2021-06-16
JPWO2020032232A1 (ja)	2021-08-10
CN113038960A (zh)	2021-06-25
BR112021002417A2 (pt)	2021-05-04
WO2020032232A1 (fr)	2020-02-13
CA3108051A1 (fr)	2020-02-13

Publication	Publication Date	Title
HUE058687T2 (hu)	2022-09-28	Azonnali elõkészítés
CA186701S (fr)	2021-04-09	Bague
DK3794042T5 (da)	2024-08-19	Anti-muc1-exatecet-antistof-lægemiddelkonjugat
EP3793613C0 (fr)	2025-01-01	Immunoconjugués
MA50657A (fr)	2020-08-05	Formulations de niraparib
EP3778444C0 (fr)	2024-03-20	Installation de préparation
MA53294A (fr)	2022-05-04	Préparation de bactériophages
CA185200S (fr)	2021-01-04	Bague
EP3746081A4 (fr)	2021-10-27	Nouvelles utilisations
LT3805220T (lt)	2024-08-26	Policikliniai karbamoilpiridono dariniai, skirti živ gydymui
EP3636246A4 (fr)	2021-03-10	Préparation cosmétique émulsionnée eau-dans-huile
PT4039675T (pt)	2024-09-16	Compostos de fenil-2-hidroxi-acetilamino-2-metil-fenilo
EP3749608A4 (fr)	2021-11-10	Capteurs nanoporeux dérivés de bactériophages
EP3603642A4 (fr)	2020-09-02	Préparation pharmaceutique
IL282114A (en)	2021-05-31	Processes for preparing functionalized cyclooctenes
HUE061610T2 (hu)	2023-07-28	Készítmény
IL283900A (en)	2021-07-29	Pharmaceutical combinations
EP3885347A4 (fr)	2022-11-16	Dérivé de dihydropyrrolopyrazole
EP3758510A4 (fr)	2021-11-24	Ingrédient
EP3590514A4 (fr)	2021-01-06	Préparation pharmaceutique
EP3646866A4 (fr)	2021-03-24	Préparation pharmaceutique
PT3796975T (pt)	2023-11-15	Derivados de sulfonilaminobenzamida
HUE069648T2 (hu)	2025-03-28	Gyógyszerészeti készítmény
EP3770162A4 (fr)	2021-12-01	Dérivé de dihydrochromène
EP3741757A4 (fr)	2021-11-03	Dérivé de dihydro-indolizinone